For reconstitution technique itself, see How to Reconstitute Retatrutide Research Peptide: Easy Step-by-Step for Labs
Adverse Reactions (2% and Greater Than Placebo) in WEGOVY-treated Adults with Obesity or Overweight for Weight Reduction In a CV outcomes trial, 8,803 patients were exposed to WEGOVY for a median of 37.3 months and 8,801 patients were exposed to placebo for a median of 38.6 months [see Clinical Studies (14.1)]
Unpacking the Triple Action: GLP-1, GIP, and Glucagon Retatrutide stands out as a triple agonist, targeting GLP-1, GIP, and glucagon receptors
Side Effects Unusual moods or behaviors, thoughts of hurting yourself, feeling depressed Rash, swollen or tender glands in the neck, armpit, or groin Blistering, peeling, red skin rash Warnings Tell your doctor if you are pregnant or breastfeeding, or if you have kidney problems (including patients receiving dialysis) or lung problems
Most Ozempic side effects occur early and improve within weeks
Weight loss drugs could have cardiovascular benefits, new research shows New research has revealed that semaglutide, the active ingredient in weight loss jabs such as Wegovy and Ozempic, could reduce a persons risk of dangerous heart events such as a heart attack and stroke, regardless of the amount of weight lost
